Reflections from NAI2024 by Wafik S. El-Deiry
Recently The National Academy of Inventors (NAI) organized its 13th Annual Conference. The NAI aims to promote innovation and technology transfer, enhance the visibility of inventors and their inventions, and foster collaboration among academia, industry, and government. Attending the NAI annual conference can be beneficial for inventors, researchers, and professionals interested in learning about the latest developments in invention and innovation. .
Wafik S. El-Deiry, Senior Member of
“Appreciate session this morning on increasing women in the innovation/invention ecosystem at NAI2024.
Great panel discussion.”
“Honored to meet Dr. Paul Sanberg, President of the NAI and attend sessions at NAI2024.”
“Dr. Paul Sanberg presides and Elizabeth Dougherty mc’s the NAI2024 meeting. Congratulations to honorary members, new member institutions, and president’s panel.”
“Attending Campus to Commerce Panel at NAI2024.
The NSF (U.S. National Science Foundation) invests in Rhode Island including businesses.
“Such an honor to be inducted this evening as Senior Member of National Academy of Inventors.
Proud to be at Brown University, an NAI member institution, and to be a part of Rhode Island’s innovation ecosystem.
Thanks to El-Deiry Lab members for 3 decades of research discoveries that have translated and continue to translate. The lab moved tree times in 15 years but the impact has been sustained.”
“Great to meet Derrick Brent, Deputy Undersecretary of Commerce for IP, USPTO (who has a sense of humor) and Dr. Alya Limayem who told me about biopolymers and zinc oxide to target multi-drug resistant bacteria.”
Source: Wafik S. El-Deiry/X
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.Dr.
El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.